Tibet releases work plan for COVID-19 downgrade
2023-01-13 08:50
Expert interprets nation's new COVID-19 treatment protocol
2023-01-13 07:00
Expert: COVID-19 risk minimal during holiday
2023-01-12 19:05
Preparedness ramped up at key locations for holiday
2023-01-12 09:12
Special teams pitch in to fight virus in Zhejiang
2023-01-12 09:11
Talks on domestic production of Paxlovid ongoing
2023-01-12 08:56
Class B downgrade brings back a sense of normality
2023-01-12 07:16
COVID drug Molnupiravir expected to hit Chinese market this week
2023-01-11 22:22
Access to cheaper dental implants from March
2023-01-11 21:15
Volunteers' and neighbors' role stressed in combating COVID-19
2023-01-11 18:07
State medical insurance to cover Pfizer's Paxlovid until March 31
2023-01-11 17:22
China in talks with Pfizer to manufacture COVID-19 drug domestically
2023-01-11 16:31
Authorities can take action to limit COVID-19 spread in rural areas
2023-01-11 15:28
Hebei doctors reach out to assist rural residents
2023-01-11 09:07
Clinics help with post-COVID rehab
2023-01-11 09:01
Monitoring of virus to remain, city official says
2023-01-11 09:00
Public responds to call for blood donations
2023-01-11 08:58
Chinese COVID-19 pill coming soon
2023-01-10 19:28
Beijing shifting to new modes of COVID control
2023-01-10 17:22
Explainer: Experts on key COVID-19 concerns through FAQs
2023-01-10 15:29- Report on Shenzhen-Jiangmen railway collapse documents regulation violations
- GX Foundation opens its global headquarters in Hong Kong
- China's success in development empowers Global South
- Study explains why Chang'e 6 moon soil is unexpectedly sticky
- Rare Sapria himalayana once again enters blooming period in Yunnan
- Shenzhou XXII to launch with full cargo load
